These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

700 related articles for article (PubMed ID: 24286589)

  • 1. Modeling human neurological disorders with induced pluripotent stem cells.
    Imaizumi Y; Okano H
    J Neurochem; 2014 May; 129(3):388-99. PubMed ID: 24286589
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induced pluripotent stem cell research: a revolutionary approach to face the challenges in drug screening.
    Song M; Paul S; Lim H; Dayem AA; Cho SG
    Arch Pharm Res; 2012 Feb; 35(2):245-60. PubMed ID: 22370779
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stem cell applications in regenerative medicine for neurological disorders.
    Liu SP; Fu RH; Huang SJ; Huang YC; Chen SY; Chang CH; Liu CH; Tsai CH; Shyu WC; Lin SZ
    Cell Transplant; 2013; 22(4):631-7. PubMed ID: 23127757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Accelerating progress in induced pluripotent stem cell research for neurological diseases.
    Ito D; Okano H; Suzuki N
    Ann Neurol; 2012 Aug; 72(2):167-74. PubMed ID: 22926850
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induced pluripotent stem cells as a new strategy for cardiac regeneration and disease modeling.
    Iglesias-García O; Pelacho B; Prósper F
    J Mol Cell Cardiol; 2013 Sep; 62():43-50. PubMed ID: 23643470
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A challenge towards the clinical application of induced pluripotent stem cell technology for the treatment of Parkinson's disease].
    Morizane A; Takahashi J
    Brain Nerve; 2012 Jan; 64(1):29-37. PubMed ID: 22223499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induced pluripotent stem cells: a new technology to study human diseases.
    Vitale AM; Wolvetang E; Mackay-Sim A
    Int J Biochem Cell Biol; 2011 Jun; 43(6):843-6. PubMed ID: 21458591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic potential of motor neurons differentiated from embryonic stem cells and induced pluripotent stem cells.
    López-González R; Velasco I
    Arch Med Res; 2012 Jan; 43(1):1-10. PubMed ID: 22293229
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human pluripotent stem cells as tools for neurodegenerative and neurodevelopmental disease modeling and drug discovery.
    Corti S; Faravelli I; Cardano M; Conti L
    Expert Opin Drug Discov; 2015 Jun; 10(6):615-29. PubMed ID: 25891144
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induced pluripotent stem cells and neurological disease models.
    Cai S; Chan YS; Shum DK
    Sheng Li Xue Bao; 2014 Feb; 66(1):55-66. PubMed ID: 24553870
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generation of mouse induced pluripotent stem cells from different genetic backgrounds using Sleeping beauty transposon mediated gene transfer.
    Muenthaisong S; Ujhelly O; Polgar Z; Varga E; Ivics Z; Pirity MK; Dinnyes A
    Exp Cell Res; 2012 Nov; 318(19):2482-9. PubMed ID: 22846649
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induced pluripotent stem cells: opportunities as research and development tools in 21st century drug discovery.
    Rowntree RK; McNeish JD
    Regen Med; 2010 Jul; 5(4):557-68. PubMed ID: 20632859
    [TBL] [Abstract][Full Text] [Related]  

  • 13. iPS cells: a source of cardiac regeneration.
    Yoshida Y; Yamanaka S
    J Mol Cell Cardiol; 2011 Feb; 50(2):327-32. PubMed ID: 21040726
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Translational prospects for human induced pluripotent stem cells.
    Csete M
    Regen Med; 2010 Jul; 5(4):509-19. PubMed ID: 20632855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The potential of induced pluripotent stem cells in models of neurological disorders: implications on future therapy.
    Crook JM; Wallace G; Tomaskovic-Crook E
    Expert Rev Neurother; 2015 Mar; 15(3):295-304. PubMed ID: 25664599
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induced pluripotent stem cell-derived hepatocytes as an alternative to human adult hepatocytes.
    Katsuda T; Sakai Y; Ochiya T
    J Stem Cells; 2012; 7(1):1-17. PubMed ID: 23550341
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Induced pluripotent stem (iPS) cell-based cell therapy for muscular dystrophy: current progress and future prospects].
    Nishiyama T; Takeda S
    Brain Nerve; 2012 Jan; 64(1):39-46. PubMed ID: 22223500
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genome editing in induced pluripotent stem cells.
    Cheng LT; Sun LT; Tada T
    Genes Cells; 2012 Jun; 17(6):431-8. PubMed ID: 22487259
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Future perspective of induced pluripotent stem cells for diagnosis, drug screening and treatment of human diseases.
    Lian Q; Chow Y; Esteban MA; Pei D; Tse HF
    Thromb Haemost; 2010 Jul; 104(1):39-44. PubMed ID: 20539907
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Uncertain translation, uncertain benefit and uncertain risk: ethical challenges facing first-in-human trials of induced pluripotent stem (ips) cells.
    Fung RK; Kerridge IH
    Bioethics; 2013 Feb; 27(2):89-96. PubMed ID: 21726264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.